The RUNX Family Defines Trk Phenotype and Aggressiveness of Human Neuroblastoma Through Regulation of P53 and MYCN

Overview

Journal Cells

Publisher MDPI

Specialties Biochemistry
Biophysics
Cell Biology
Molecular Biology

Date 2023 Feb 25

PMID 36831211

Authors

Kiyohiro Ando

Akira Nakagawara

Affiliations

Soon will be listed here.

Abstract

The Runt-related transcription factor (RUNX) family, which is essential for the differentiation of cells of neural crest origin, also plays a potential role in neuroblastoma tumorigenesis. Consecutive studies in various tumor types have demonstrated that the RUNX family can play either pro-tumorigenic or anti-tumorigenic roles in a context-dependent manner, including in response to chemotherapeutic agents. However, in primary neuroblastomas, RUNX3 acts as a tumor-suppressor, whereas RUNX1 bifunctionally regulates cell proliferation according to the characterized genetic and epigenetic backgrounds, including MYCN oncogenesis. In this review, we first highlight the current knowledge regarding the mechanism through which the RUNX family regulates the neurotrophin receptors known as the tropomyosin-related kinase (Trk) family, which are significantly associated with neuroblastoma aggressiveness. We then focus on the possible involvement of the RUNX family in functional alterations of the p53 family members that execute either tumor-suppressive or dominant-negative functions in neuroblastoma tumorigenesis. By examining the tripartite relationship between the RUNX, Trk, and p53 families, in addition to the oncogene MYCN, we endeavor to elucidate the possible contribution of the RUNX family to neuroblastoma tumorigenesis for a better understanding of potential future molecular-based therapies.

References

Lau C, Harris C, Lu X, Perlaky L, Gogineni S, Chintagumpala M . Frequent amplification and rearrangement of chromosomal bands 6p12-p21 and 17p11.2 in osteosarcoma. Genes Chromosomes Cancer. 2003; 39(1):11-21. DOI: 10.1002/gcc.10291. View

Nikoletopoulou V, Lickert H, Frade J, Rencurel C, Giallonardo P, Zhang L . Neurotrophin receptors TrkA and TrkC cause neuronal death whereas TrkB does not. Nature. 2010; 467(7311):59-63. DOI: 10.1038/nature09336. View

Attiyeh E, London W, Mosse Y, Wang Q, Winter C, Khazi D . Chromosome 1p and 11q deletions and outcome in neuroblastoma. N Engl J Med. 2005; 353(21):2243-53. DOI: 10.1056/NEJMoa052399. View

Dolle L, Adriaenssens E, El Yazidi-Belkoura I, Le Bourhis X, Nurcombe V, Hondermarck H . Nerve growth factor receptors and signaling in breast cancer. Curr Cancer Drug Targets. 2004; 4(6):463-70. DOI: 10.2174/1568009043332853. View

Ishimoto O, Kawahara C, Enjo K, Obinata M, Nukiwa T, Ikawa S . Possible oncogenic potential of DeltaNp73: a newly identified isoform of human p73. Cancer Res. 2002; 62(3):636-41. View

Gaiddon C, Lokshin M, Ahn J, Zhang T, Prives C . A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain. Mol Cell Biol. 2001; 21(5):1874-87. PMC: 86759. DOI: 10.1128/MCB.21.5.1874-1887.2001. View

Nakagawara A, Azar C, Scavarda N, Brodeur G . Expression and function of TRK-B and BDNF in human neuroblastomas. Mol Cell Biol. 1994; 14(1):759-67. PMC: 358424. DOI: 10.1128/mcb.14.1.759-767.1994. View

Inoue K, Shiga T, Ito Y . Runx transcription factors in neuronal development. Neural Dev. 2008; 3:20. PMC: 2531103. DOI: 10.1186/1749-8104-3-20. View

Ponzoni M, Bachetti T, Corrias M, Brignole C, Pastorino F, Calarco E . Recent advances in the developmental origin of neuroblastoma: an overview. J Exp Clin Cancer Res. 2022; 41(1):92. PMC: 8915499. DOI: 10.1186/s13046-022-02281-w. View

10.

Pratap J, Wixted J, Gaur T, Zaidi S, Dobson J, Gokul K . Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells. Cancer Res. 2008; 68(19):7795-802. PMC: 2596479. DOI: 10.1158/0008-5472.CAN-08-1078. View

11.

Maris J, Guo C, Blake D, White P, Hogarty M, Thompson P . Comprehensive analysis of chromosome 1p deletions in neuroblastoma. Med Pediatr Oncol. 2001; 36(1):32-6. DOI: 10.1002/1096-911X(20010101)36:1<32::AID-MPO1009>3.0.CO;2-0. View

12.

Ando K, Nakagawara A . Acceleration or Brakes: Which Is Rational for Cell Cycle-Targeting Neuroblastoma Therapy?. Biomolecules. 2021; 11(5). PMC: 8157238. DOI: 10.3390/biom11050750. View

13.

Liebl D, Klesse L, Tessarollo L, Wohlman T, Parada L . Loss of brain-derived neurotrophic factor-dependent neural crest-derived sensory neurons in neurotrophin-4 mutant mice. Proc Natl Acad Sci U S A. 2000; 97(5):2297-302. PMC: 15795. DOI: 10.1073/pnas.040562597. View

14.

Asgharzadeh S, Pique-Regi R, Sposto R, Wang H, Yang Y, Shimada H . Prognostic significance of gene expression profiles of metastatic neuroblastomas lacking MYCN gene amplification. J Natl Cancer Inst. 2006; 98(17):1193-203. DOI: 10.1093/jnci/djj330. View

15.

Moll U, Ostermeyer A, Haladay R, Winkfield B, Frazier M, Zambetti G . Cytoplasmic sequestration of wild-type p53 protein impairs the G1 checkpoint after DNA damage. Mol Cell Biol. 1996; 16(3):1126-37. PMC: 231095. DOI: 10.1128/MCB.16.3.1126. View

16.

Date Y, Ito K . Oncogenic RUNX3: A Link between p53 Deficiency and MYC Dysregulation. Mol Cells. 2020; 43(2):176-181. PMC: 7057839. DOI: 10.14348/molcells.2019.0285. View

17.

Choi A, Illendula A, Pulikkan J, Roderick J, Tesell J, Yu J . RUNX1 is required for oncogenic and enhancer activity in T-cell acute lymphoblastic leukemia. Blood. 2017; 130(15):1722-1733. PMC: 5639483. DOI: 10.1182/blood-2017-03-775536. View

18.

Chen C, Broom D, Liu Y, de Nooij J, Li Z, Cen C . Runx1 determines nociceptive sensory neuron phenotype and is required for thermal and neuropathic pain. Neuron. 2006; 49(3):365-77. DOI: 10.1016/j.neuron.2005.10.036. View

19.

Koh C, Iwata T, Zheng Q, Bethel C, Yegnasubramanian S, De Marzo A . Myc enforces overexpression of EZH2 in early prostatic neoplasia via transcriptional and post-transcriptional mechanisms. Oncotarget. 2011; 2(9):669-83. PMC: 3248223. DOI: 10.18632/oncotarget.327. View

20.

Yoshikawa M, Senzaki K, Yokomizo T, Takahashi S, Ozaki S, Shiga T . Runx1 selectively regulates cell fate specification and axonal projections of dorsal root ganglion neurons. Dev Biol. 2007; 303(2):663-74. DOI: 10.1016/j.ydbio.2006.12.007. View